Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

Core Viewpoint - Teva Pharmaceutical Industries Ltd. will release its third quarter 2025 financial results on November 5, 2025, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET [1] Group 1 - The conference call will be accessible via a live webcast on Teva's website, with a replay available within 24 hours after the call [2] - Teva is recognized as a leading innovative biopharmaceutical company, supported by a strong generics business, with over 120 years of commitment to addressing patient needs [3] Group 2 - The company emphasizes its focus on innovation in neuroscience and immunology, as well as providing complex generic medicines, biosimilars, and pharmacy brands globally [3]